- Report
- September 2025
- 464 Pages
Global
From €5146EUR$5,850USD£4,465GBP
- Report
- September 2025
- 475 Pages
Global
From €5146EUR$5,850USD£4,465GBP
- Report
- September 2025
- 279 Pages
Global
From €5146EUR$5,850USD£4,465GBP
- Report
- September 2025
- 468 Pages
Global
From €5146EUR$5,850USD£4,465GBP
- Report
- September 2025
- 281 Pages
Global
From €5146EUR$5,850USD£4,465GBP
- Report
- September 2025
- 480 Pages
Global
From €5146EUR$5,850USD£4,465GBP
- Report
- September 2025
- 170 Pages
Global
From €5146EUR$5,850USD£4,465GBP
- Report
- September 2025
- 470 Pages
Global
From €5146EUR$5,850USD£4,465GBP
- Report
- September 2025
- 273 Pages
Global
From €5146EUR$5,850USD£4,465GBP
- Report
- September 2025
- 374 Pages
Global
From €5146EUR$5,850USD£4,465GBP
- Report
- September 2025
- 484 Pages
Global
From €5146EUR$5,850USD£4,465GBP
- Report
- September 2025
- 177 Pages
Global
From €5146EUR$5,850USD£4,465GBP
- Report
- September 2025
- 378 Pages
Global
From €5146EUR$5,850USD£4,465GBP
- Report
- September 2025
- 467 Pages
Global
From €5146EUR$5,850USD£4,465GBP
- Report
- September 2025
- 277 Pages
Global
From €5146EUR$5,850USD£4,465GBP
- Report
- September 2025
- 179 Pages
Global
From €5146EUR$5,850USD£4,465GBP
- Report
- September 2025
- 483 Pages
Global
From €5146EUR$5,850USD£4,465GBP
- Report
- September 2025
- 478 Pages
Global
From €5146EUR$5,850USD£4,465GBP
- Report
- September 2025
- 207 Pages
Global
From €5146EUR$5,850USD£4,465GBP
- Report
- September 2025
- 204 Pages
Global
From €5146EUR$5,850USD£4,465GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more